SenesTech Future Growth
Future criteria checks 2/6
SenesTech is forecast to grow earnings and revenue by 16.7% and 44.5% per annum respectively while EPS is expected to grow by 63.5% per annum.
Key information
16.7%
Earnings growth rate
63.5%
EPS growth rate
| Pharmaceuticals earnings growth | 21.2% |
| Revenue growth rate | 44.5% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 28 Dec 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8 | -6 | -4 | N/A | 1 |
| 12/31/2025 | 5 | -7 | -6 | N/A | 1 |
| 12/31/2024 | 2 | -8 | -7 | N/A | 1 |
| 12/31/2023 | 1 | -8 | -2 | N/A | 1 |
| 9/30/2023 | 1 | -8 | -8 | -8 | N/A |
| 6/30/2023 | 1 | -9 | -8 | -8 | N/A |
| 3/31/2023 | 1 | -9 | -9 | -9 | N/A |
| 12/31/2022 | 1 | -10 | -9 | -9 | N/A |
| 9/30/2022 | 1 | -10 | -8 | -8 | N/A |
| 6/30/2022 | 1 | -10 | -8 | -8 | N/A |
| 3/31/2022 | 1 | -9 | -8 | -8 | N/A |
| 12/31/2021 | 1 | -8 | -8 | -8 | N/A |
| 9/30/2021 | 1 | -8 | -8 | -8 | N/A |
| 6/30/2021 | 0 | -8 | -8 | -8 | N/A |
| 3/31/2021 | 0 | -7 | -7 | -7 | N/A |
| 12/31/2020 | 0 | -8 | -7 | -7 | N/A |
| 9/30/2020 | 0 | -9 | -8 | -7 | N/A |
| 6/30/2020 | 0 | -10 | -8 | -8 | N/A |
| 3/31/2020 | 0 | -10 | -8 | -8 | N/A |
| 12/31/2019 | 0 | -10 | -8 | -8 | N/A |
| 9/30/2019 | 0 | -10 | -8 | -8 | N/A |
| 6/30/2019 | 0 | -10 | -9 | -8 | N/A |
| 3/31/2019 | 0 | -12 | -9 | -9 | N/A |
| 12/31/2018 | 0 | -12 | -9 | -9 | N/A |
| 9/30/2018 | 0 | -12 | -9 | -9 | N/A |
| 6/30/2018 | 0 | -12 | -8 | -8 | N/A |
| 3/31/2018 | 0 | -11 | -9 | -8 | N/A |
| 12/31/2017 | 0 | -12 | -10 | -9 | N/A |
| 9/30/2017 | 0 | -14 | -11 | -10 | N/A |
| 6/30/2017 | 0 | -13 | N/A | -10 | N/A |
| 3/31/2017 | 0 | -12 | N/A | -9 | N/A |
| 12/31/2016 | 0 | -11 | N/A | -7 | N/A |
| 9/30/2016 | 0 | -14 | N/A | -5 | N/A |
| 6/30/2016 | 0 | -20 | N/A | -4 | N/A |
| 3/31/2016 | 0 | -20 | N/A | -4 | N/A |
| 12/31/2015 | 0 | -18 | N/A | -4 | N/A |
| 12/31/2014 | 0 | -7 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SE81 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SE81 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SE81 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SE81's revenue (44.5% per year) is forecast to grow faster than the German market (4.8% per year).
High Growth Revenue: SE81's revenue (44.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SE81's Return on Equity is forecast to be high in 3 years time